Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
The European Respiratory Journal
|
June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
I Borget, J Cadranel, J-P Pignon, et al.
Endocrine-Related Cancer
|
December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2016
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer
Livia Lamartina, S Ippolito, M Danis, et al.
BMC Cancer
|
November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)
C Raynaud, L Greillier, J Mazieres, et al.
Endocrine
|
March 10, 2020
Locally unresectable differentiated thyroid cancer: outcomes and perspectives
L Lamartina, Y Godbert, C Nascimento, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2011
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients
M Brassard, I Borget, A Edet-Sanson, et al.
Endocrine-Related Cancer
|
March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
J Hadoux, D Malka, D Planchard, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 14, 2015
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up
C Lepoutre-Lussey, C Caramella, F Bidault, et al.
ESMO Open
|
March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET
J Hadoux, J Hernando, K H Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libé, I Borget, C L Ronchi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
The European Respiratory Journal
|
June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
I Borget, J Cadranel, J-P Pignon, et al.
Endocrine-Related Cancer
|
December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2016
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer
Livia Lamartina, S Ippolito, M Danis, et al.
BMC Cancer
|
November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)
C Raynaud, L Greillier, J Mazieres, et al.
Endocrine
|
March 10, 2020
Locally unresectable differentiated thyroid cancer: outcomes and perspectives
L Lamartina, Y Godbert, C Nascimento, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2011
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients
M Brassard, I Borget, A Edet-Sanson, et al.
Endocrine-Related Cancer
|
March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
J Hadoux, D Malka, D Planchard, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 14, 2015
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up
C Lepoutre-Lussey, C Caramella, F Bidault, et al.
ESMO Open
|
March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET
J Hadoux, J Hernando, K H Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libé, I Borget, C L Ronchi, et al.
Page
of 4